HEPATITIS C, CHRONIC
Clinical trials for HEPATITIS C, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS C, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS C, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a blood pressure drug reverse liver damage in hepatitis c?
Disease control CompletedThis study tested whether adding prazosin, a drug usually used for high blood pressure, to standard hepatitis C treatment could reduce liver scarring. 112 adults with chronic hepatitis C (genotype 1 or 4) and severe liver fibrosis took part. Researchers measured changes in liver …
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Second chance: new combo tackles hepatitis c in HIV patients
Disease control CompletedThis study tested a combination of peginterferon alfa2a and ribavirin in 17 HIV-positive people with chronic hepatitis C who had not responded to earlier treatment. Participants received weekly injections and daily pills for 48 weeks. The main goal was to see if the virus became …
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Blood pressure drug may halt liver damage in hep c patients
Disease control CompletedThis study tested whether irbesartan, a blood pressure medication, can slow the progression of liver scarring (fibrosis) in adults with chronic hepatitis C who cannot take or did not respond to antiviral therapy. Over two years, 166 participants took either irbesartan or a placeb…
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope: hepatitis c drugs after liver cancer treatment
Disease control CompletedThis study tested whether interferon-free drug combinations can cure hepatitis C in 150 people who had been successfully treated for liver cancer. Participants took pills like sofosbuvir and ribavirin for 12 weeks. The main goal was to see if the virus stayed undetectable 12 week…
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE3 • Sponsor: National Hepatology & Tropical Medicine Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for HIV patients with Hard-to-Treat hepatitis c
Disease control CompletedThis phase 2 study tested a combination of three drugs—telaprevir, peginterferon, and ribavirin—in 70 adults with both HIV and hepatitis C who had not been helped by standard treatment before. The goal was to see if this triple therapy could clear the hepatitis C virus from the b…
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New pill combo aims to cure hepatitis c in just 8 weeks
Disease control CompletedThis study tested a new combination of two antiviral pills, bemnifosbuvir and ruzasvir, taken once daily for 8 weeks in 275 adults with chronic hepatitis C. The main goal was to see if the virus was still undetectable 12 weeks after treatment ended. The trial is now complete, and…
Matched conditions: HEPATITIS C, CHRONIC
Phase: PHASE2 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Hepatitis c care at opioid clinics boosts treatment access
Disease control CompletedThis study tested whether offering hepatitis C treatment at the same clinic where people receive opioid therapy leads to better outcomes than referring them to a separate infectious disease clinic. About 298 people on opioid therapy with chronic hepatitis C took part. The goal wa…
Matched conditions: HEPATITIS C, CHRONIC
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
New study tests faster hepatitis c detection for drug users
Knowledge-focused CompletedThis study looked at two faster ways to test for hepatitis C in people who recently injected drugs and visit needle exchange programs. One method uses a fingerstick test with results in about an hour, and the other uses a dried blood spot sent to a lab. The goal was to see if the…
Matched conditions: HEPATITIS C, CHRONIC
Phase: NA • Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC